丹麦公司Novo Holdings完成了165亿美元的Catalent制药公司收购. Danish firm Novo Holdings completes $16.5B acquisition of pharmaceutical company Catalent.

丹麦投资公司 Novo Holdings 以 165 亿美元完成了对大型制药公司 Catalent Inc. 的收购。 Novo Holdings, a Danish investment firm, has completed its $16.5 billion acquisition of Catalent Inc., a major pharmaceutical manufacturing company. 加泰隆尼亚公司股东将获得每股现金63.50美元,比2月股票结账价格高16.5%的溢价。 Catalent’s stockholders will receive $63.50 per share in cash, marking a 16.5% premium over the stock's February closing price. 康泰伦特现在是一家私营公司，还将获得三个额外的生产基地，以增强其制药服务。 Catalent, now a private company, will also gain three additional manufacturing sites, enhancing its pharmaceutical services.